J Neurol Neurosurg Psychiatry 1999;66:228-232 ( February )
Short report
Tc-99m HMPAO SPECT in the evaluation of Alzheimer's disease:
correlation between neuropsychiatric evaluation and CBF images
Muhammad Babar Imran,a
Ryuta Kawashima,a
Shuichi Awata,b
Kazunori Sato,a
Shigeo Kinomura,a
Shuichi Ono,a
Mitsumoto Sato,b
Hiroshi Fukudaa
a Department of
Nuclear Medicine and Radiology, Institute of Development, Aging and
Cancer, Tohoku University, Sendai, Japan, b Department of Psychiatry, Tohoku
University Hospital, Sendai, Japan
Correspondence to: Dr M Babar Imran, Department of Nuclear Medicine and Radiology,
Division of Brain Sciences, Institute of Development, Aging and Cancer,
Tohoku University 4-1, Seiryo machi, Aoba - ku, Sendai, Japan
980-8575. Telephone 0081 22 717 8559; fax 0081 22 717 8575.
Received 23 March 1998 and in revised form 6 July 1998;
Accepted 10 August
1998
 |
Abstract |
The purpose of this study was to evaluate the effects of
various covariants on the distribution pattern of Tc-99m HMPAO in patients with Alzheimer's disease by correlation analysis. Twenty patients with Alzheimer's disease and 15 age matched normal subjects participated. Tc-99m HMPAO brain SPECT and x
ray computed tomography (CT) were acquired for each subject. SPECT
images were transformed to a standard size and shape by automated image
registration (AIR) and were used for group comparison by means of
SPM96. Voxel based covariance analysis was performed on standardised
images taking the age of patients, severity of disease (clinical
dementia rating scale, mini mental state examination, physical self
maintenance scale), and atrophy indices as variables. There was
significantly decreased regional cerebral blood flow (rCBF) in the
frontal, parietal, and temporal regions in the patient group
(p<0.001), more marked in those patients having severe dementia.
Covariance analysis disclosed that aging and severity of disease have a
pronounced effect on rCBF, especially that of the left parietal region.
(J Neurol Neurosurg Psychiatry 1999;66:228-232)
Keywords:
Tc-99m HMPAO SPECT;
automated image registration;
Alzheimer's disease
 |
Introduction |
Single
photon emission computerised tomography (SPECT) is being widely used
for cerebral blood flow (CBF) studies. These studies provide unique
information for the identification of functional abnormalities relevant
to Alzheimer's disease.1-3 The appearance of SPECT CBF
images in patients with Alzheimer's disease is dependent on complex
interactions of influencing factors that include age of the patient,
severity and duration of disease, and brain atrophy in addition to
variation due to methodology and instrumentation. Effects of these
variables have not been objectively evaluated. We have considered this
issue by using the concept of group statistics with the help of an
image registration technique.
There are various techniques available for image registration and
standardisation. Automated image registration (AIR, version 3.0) is a
program, recently developed by Woods et
al,4 5 which standardises any brain image with
respect to another specified reference image using linear and
non-linear models. It has been validated for various types of
registrations, including intersubject transformation of brain SPECT
images.6
In the present study we used AIR to standardise the size and shape of
individual brain SPECT images of patients with Alzheimer's disease and
age matched normal subjects. Arithmetic and statistical calculations
were performed on voxel based values of individual images, and these
were used to generate three dimensional group mean images for further
analyses. Effects of atrophy, age of individual patients, and severity
of disease were evaluated by variance analysis.
 |
Materials and methods |
SUBJECTS
All the procedures were approved by the ethics committee for
clinical research of Tohoku University. A total of 20 patients with
Alzheimer's disease (age 71.1 (SD 7.4) detailed profiles listed in the
table) and 15 normal subjects (age 70.2 (SD 8.4) participated in the
study. All the subjects were right handed as assessed by the Hatla
Nakata handedness inventory. Written informed consent was obtained in
all cases according to the declaration of human rights of Helsinki
1975.
None of the control subjects had a lifetime history of any psychiatric
disorders, including drug misuse. Their medical histories and physical
examinations did not disclose any signs or symptoms that could effect
CBF studies. Brain CT taken immediately after SPECT was rated normal by radiologists.
Patients were diagnosed as having probable Alzheimer's disease
according to the diagnostic and statistical manual of mental disorders
(DSM-IV) and National Institute for Neurological and Communicative
Disorders and Stroke/Alzheimer's Disease and Related Disorders
Association (NINCDS-ADRDA) by experienced psychiatrists. Severity of
disease was assessed on mini mental state examination (MMSE) and
clinical dementia rating (CDR) scales. Activity of daily living was
assessed by physical self maintenance scale (PSMS). Patients with CDR
2 were placed in group A (severe dementia) and those having CDR
1
were placed in group B (mild dementia). SPECT of patients with
Alzheimer's disease was done immediately after the initial diagnosis.
However, scans were only included in the present study of those
subjects for whom after 1 year of follow up the diagnosis remained the
same. This strict screening was adopted to avoid inclusion of falsely
diagnosed Alzheimer's disease.
IMAGE ACQUISITION AND PROCESSING
A SPECT scanner (SPECT-2000H, Hitachi Medico Corp,
Japan)7 was used to acquire data after a bolus injection
of 1036 MBq Tc-99m HMPAO. Image reconstruction was performed by
filtered back projection using a Butterworth filter (dimension 12, cut
off 0.25 cycles/pixel). Attenuation correction was made numerically
with a uniform coefficient factor (0.1/cm). Correction for scatter photons was not performed. After SPECT measurements, CT was obtained. All reconstructed images were transferred to a UNIX work station for
further analysis.
IMAGE STANDARDISATION AND DATA ANALYSIS
SPECT images were globally normalised with averaging the whole
brain radioactivity to 100 counts/pixel. After this normalisation, all
SPECT images were registered with respect to a reference image to make
target images similar in size and shape using linear and non-linear
parometers. The standardised images were used to calculate the mean
images for patients and control subjects. Group comparison of patients
and controls was performed on a voxel by voxel basis using statistical
parameteric mapping (SPM96).
A brain atrophy index (BAI) was calculated for each subject using a
computer program and the morphometric data from CT.8
After specifying the appropriate design matrix, the covariant effects
(negative correlation) of aging and atrophy, severity of disease (CDR
and MMS score), and activities of daily living (PSMS) on CBF were
estimated according to the general linear model at each and every voxel
by SPM96. Results of statistical calculations were displayed as z maps
(p<0.001).
 |
Results |
Figure 1, panel I shows mean rCBF images of patients (top row
severe dementia group A, middle row mild dementia group B, and bottom
row age matched control subjects. Patient group images showed bilateral
parietotemporal deficits, along with decreased CBF in the upper frontal
region. These findings were more marked on the left side. In the
temporal lobe, the medial area showed more marked deficits than the
lateral region. All these described areas demonstrated a pronounced
decrease in CBF in the severe dementia group A. Ventricular/periventricular regions, and the distance between the
caudate nuclei and lateral sulci were larger in the patient group than
in the normal group. These findings were consistent with the
morphometric data from CT with calculated atrophy indices of 0.974 (SD
0.012) and 0.904 SD (0.042) for controls and patients respectively.
Within the group of patients, atrophy was more marked in group A than
in group B.

View larger version (63K):
[in this window]
[in a new window]
|
Figure 1
(I) Group mean Tc-99m HMPAO SPECT images of
Alzheimer's patients and normal subjects. The mean global value is 100 counts/pixel. Transverse slices are with reference to the Telairach
grid and parallel to intercommissural line. The anterior represents the
top of the image and the subject's right is on the left. Top row shows
mean images of group A patients with severe dementia, middle row shows
mean images of group B patients with early and mild dementia, and the
bottom row shows mean images of normal controls. (II) z map (mean image
of normal subjects mean image of patients with Alzheimer's disease)
displayed on a glass brain. Significant differences in frontal,
parietal, and temporal regions are shown. That for periventricular
regions is due to the effect of global normalisation. (III) z Map (mean
image of Alzheimer's disease group B mean image of Alzheimer's
disease group A) displayed on a glass brain. A significant difference
in the left parietal region is shown.
|
|
The comparison between patients and controls (fig 1 panel II) showed a
significant difference in the parietotemporal and frontal regions as
well as the periventricular area, in line with the findings of mean
images. Figure 1, panel III shows a comparison between patients of
group A and group B. A significant difference was found for the left
parietal region. Figure 2 shows the results of voxel based covariance
analysis. Among the cortical regions, the left parietal area showed a
significant correlation with the severity of disease scaled on CDR as
well as MMSE (fig 2, panels I and II). The effect of aging is shown in
fig 2 panels III and IV (Alzheimer's disease group and normal controls
respectively). A difference in the pattern of aging was found between
the two groups. In the Alzheimer's disease group, CBF of the left
parietal region showed a significantly strong correlation with age.
Correlation maps for atrophy and the PSMS score did not show any
particular pattern of correlation, indicating no specific relation of
these two variables with blood flow in the intact cortical regions.

View larger version (42K):
[in this window]
[in a new window]
|
Figure 2
(I and II) Statistical maps showing correlation
severity of disease scaled on CDR and MMS versus rCBF (Tc-99m HMPAO)
images of Alzheimer's patients. (III and IV) Statistical maps showing
correlation between age (in years at the time of SPECT) of patients and
controls v rCBF (Tc-99m HMPAO) images.
|
|
 |
Discussion |
There are two important findings of this study. Firstly, bilateral
parietotemporal deficits of CBF along with a definite decrease in blood
flow in the frontal region were established in patients with
Alzheimer's disease compared with normal controls. This is at least
partly consistent with previous studies, which showed parietotemporal
deficits as characteristic findings of Alzheimer's disease.9 10 However, a decrease in frontal region CBF at an early stage of Alzheimer's dementia might be an effect of signal averaging, as such procedures are well known to increase sensitivity by
increasing the signal to noise ratio.11 The second finding is the significant correlation of left parietal CBF values with patient
age and severity of dementia. This suggests that metabolic images not
only provide diagnostic and prognostic information but also help in
determination of the stage of disease.
The regional distribution of Tc-99m HMPAO in the brain is influenced by
a complex combination of factors.12 Although important, the sources of variation in measurements due to technical factors (such
as statistical noise and positioning errors) can be either avoided
altogether or neglected safely without any risk of loss in sensitivity
and specificity of the test in routine clinical studies. However,
certain factors such as the effect of aging cannot be filtered out
easily. Moreover, the pattern of influence of all such factors on
cerebral flow and perfusion images is not well understood. Their
behaviour alone or in combination with other factors might be linear,
curvilinear, or may actually not follow any particular model. In our
population, CBF values on the left side were generally lower, bilateral
asymmetry was not significant in the normal population,
however.6 From the present research it is clear that age
and severity of Alzheimer's disease have negative correlational
effects on CBF in the left parietal region in patients with
Alzheimer's disease.
Changes in functional coupling between various regions of the brain
leading to a decrease in CBF values cannot be explained by any single
factor. Interestingly, although atrophy caused expansion of CSF space,
the effects on blood flow of shrunken but intact cortical areas were
minimal. Functional abnormalities may be detected earlier than
counterpart anatomical changes on morphometric data.
In the present study we coupled image analysis of consecutive cases
with a clinical follow up of sufficient duration to reduce diagnostic
uncertainty. To confirm the diagnosis of Alzheimer's disease, a follow
up of at least 1 year and then re-examination by a psychiatrist were
made mandatory for inclusion of SPECT CBF images in the analysis.
Because medication may effect CBF images through metabolic
alterations,13-15 we performed our studies before medication was started.
To our knowledge this is the first study aimed at a voxel based
covariance analysis of SPECT CBF images of patients with Alzheimer's disease after spatial normalisation of individual images with the use
of AIR.
 |
Conclusions |
Cerebral blood flow in the left parietal region correlates
strongly with stage of Alzheimer's dementia.
The age of patients as a variance factor has a more pronounced effect
on CBF in the intact cortical areas than that of atrophy.
 |
Acknowledgments |
This study was supported in part by grants in aid for
scientific research from the Ministry of Education, Science, Sports and
Culture (09044250), JSPS-RFTF (97L00202), the Telecommunication Advancement Organization, and the Ministry of Health and Welfare of Japan.
 |
References |
| 1.
|
Sharp P,
Gemmell H,
Cherryman G,
et al. Application of iodine 123 labelled isopropylamphetamine imaging to the study of dementia.
J Nucl Med
1986;27:761-768[Abstract/Free Full Text].
|
| 2.
|
Neary D,
Snowden JS,
Shields RA,
et al. Single photon emission tomography using Tc-99m HMPAO in the investigation of dementia.
J Neurol Neurosurg Psychiatry
1987;50:1101-1109[Abstract].
|
| 3.
|
Holman BL,
Johnson KA,
Gerada B,
et al. The scintigraphic appearance of Alzheimer's disease: A prospective study using Tc-99m HMPAO SPECT.
J Nucl Med
1992;33:181-185[Abstract/Free Full Text].
|
| 4.
|
Woods RP,
Grafton ST,
Holmes CJ,
et al. Automated image registration: I. General methods and intrasubject, intramodality validation.
J Comp Assist Tomogr
1998;22:141-154.
|
| 5.
|
Woods RP,
Grafton ST,
Watson JDG,
et al. Automated image registration: II. Intersubject validation of linear and nonlinear models.
J Comp Assist Tomogr
1998;22:155-165.
|
| 6.
|
Imran MB,
Kawashima R,
Sato K,
et al. Mean rCBF images of normal subjects using Tc-99m HMPAO by automated image registration (AIR).
J Nucl Med
1998;32:203-207.
|
| 7.
|
Kimura K,
Hashikawa K,
Wtani H,
et al. A new apparatus for brain imaging: four head rotating gamma single photon emission computed tomography.
J Nucl Med
1990;31:603-609[Abstract/Free Full Text].
|
| 8.
|
Takeda S,
Matsuzawa T. Brain atrophy during aging: a quantitative study using computed tomography.
J Am Geriatr Soc
1984;32:520-522[Medline].
|
| 9.
|
Haxby JV,
Grady CL,
Koss E,
et al. Heterogeneous anterior posterior metabolic patterns in Alzheimer's type dementia.
Neurology
1988;38:1853-1863[Abstract/Free Full Text].
|
| 10.
|
Duara R,
Grady CL,
Haxby JV,
et al. Positron emission tomography in Alzheimer's disease.
Neurology
1986;36:879-887[Abstract/Free Full Text].
|
| 11.
|
Fox PT,
Mintun MA,
Reiman EM,
et al. Enhanced detection of focal brain responses using intersubject averaging and change distribution analysis of subtracted PET images.
J Cereb Blood Flow Metab
1988;8:642-653[Medline].
|
| 12.
|
Marku HS,
Ring H,
Kourisk,
et al. Alteration in regional cerebral blood flow with increased temporal interhemispheric asymmetries, in normal elderly: an HMPAO study.
Nucl Med Commun
1993;14:628-633[Medline].
|
| 13.
|
Heiss WD,
Hebold H,
Klinkhammer P. Effect of piracetam on cerebral glucose metabolism in Alzheimer's diesease as measured by positron emission tomography.
J Cereb Blood Flow Metab
1988;8:613-617[Medline].
|
| 14.
|
Geaney DP,
Soer N,
Shepstone BJ,
et al. Effect of central cholinergic stimulation on regional cerebral blood flow in Alzheimer disease.
Lancet
1990;335:1484-1487[Medline].
|
| 15.
|
Imran MB,
Awata S,
Kawashima R,
et al. Follow-up of improvement in regional cerebral blood flow and mental status in Alzheimer's disease.
Clin Nucl Med
1998;23:601-603[Medline].
|
© 1999 by Journal of Neurology, Neurosurgery, and Psychiatry